arrow
D

Diana Gómez-Martín

departamento de inmunología y reumatología
H指数:31
被引数:2,895

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Obesity and COVID-19 severity independently shape adipokine dysregulation and immune cell remodeling

肥胖和COVID-19严重程度独立塑造脂肪因子失调和免疫细胞重塑

2026-09-080
OA
Disrupted Neutrophil and Myeloid Cell Homeostasis and Effector Dysfunction Drive Vasculopathy in Idiopathic Inflammatory Myopathies

特发性炎性肌病中中性粒细胞和髓系细胞稳态失衡及效应器功能障碍驱动血管病变

Cells
IF5.2
2026-06-100
OA
Disease activity and immune disbalance are key drivers of infections in patients with idiopathic inflammatory myopathies: results from the MYOTReCSZ cohort

疾病活动度和免疫失衡是特发性炎症性肌病患者感染的关键驱动因素:MYOTReCSZ队列研究结果

2025-11-040
PRE
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: a systematic review and meta-analysis

以免疫沉淀法作为参考标准评估商业性肌炎特异性自身抗体检测的分析性能:一项系统评价和荟萃分析

2025-10-270
PRE
Myeloid-derived suppressor cells and monocytes are biomarkers of the clinical phenotype and activity of psoriatic disease

髓系来源抑制细胞和单核细胞是银屑病临床表型和活动性的生物标志物

2025-09-010
PRE
Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients

未接种疫苗患者中促炎和抗炎细胞因子多态性与COVID-19严重程度的相关性

2025-08-130
OA
Mast cell activation signature as a potential biomarker in COVID-19

肥大细胞活化特征作为COVID-19的潜在生物标志物

2025-05-280
PRE
Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes

根据系统性红斑狼疮临床表型对抗中性粒细胞胞外 traps (NET) 抗体的表征

2025-05-090
PRE
Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers

尿细胞外囊泡大小亚群作为狼疮性肾炎的生物标志物

2024-10-120
OAAI
The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes
2024-03-272
OAAI
Down-Regulation-Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+T Cell Interferon-γ Production
2023-03-226
OA
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study
2023-01-137
OA